Bcg Immunotherapy

/Tag:Bcg Immunotherapy

HM2016 Abstract Number: 732

Pott’s Disease Following Intravesical Bcg Therapy

Case Presentation: Intravesical administration of Bacillus Calmette-Guerin (BCG), a live attenuated strain of Mycobacterium bovis, is used as an adjunctive therapy for superficial bladder cancer. Although mostly well tolerated, disseminated infections can occur rarely. We [...]

By | 2016-02-01T08:00:34-05:00 February 1st, 2016|Adult, Clinical Vignettes Abstracts|Comments Off on Pott’s Disease Following Intravesical Bcg Therapy